MobiHealth News March 25, 2025
The company will use the funds to invest in technology and expand into new market segments.
Amboss, a medical education company for medical students and healthcare stakeholders, closed a €240 million ($259.44 million) financing round.
The round included new primary investors KIRKBI, M&G Investments and Lightrock, with participation from existing shareholders. The company recently converted to a European stock corporation (SE).
WHAT IT DOES
Amboss helps medical students and professionals access information. Its platform includes a program designed to help students study for the U.S. medical licensing exams and national board exams.
The company will use the funds to add international markets and expand its offering to nurses and other healthcare professionals.
“We choose investors who are committed...
Today's Sponsors
Today's Sponsor